Future studies could leverage a similar approach to screen a larger number of epitopes and determine the frequency and durability of CD4+ T cell responses to LISP1 and other candidate liver stage antigens following both natural infection and attenuated sporozoite vaccination strategies. The gene discussed is CD4; the disease is infection.